Member Info for B2HS2L

source: https://www.bbc.co.uk/news/live/uk-politics-parliaments-51644076

Tests for the virus are being expanded to include people displaying flu-like symptoms at 11 hospitals and 100 GP surgeries across the UK.

Up to now, people were tested only if they displayed symptoms having recently returned from one of the countries where there has been an outbreak.

The Foreign Office has also updated its travel advice, warning against all but essential travel to 11 quarantined towns in Italy, and advising to people to self-isolate on their return.

However Health Secretary Matt Han**** has said there were no plans to stop flights from Italy, which attracts about three million British visitors each year.

Four schools have shut completely for a week to carry out a "deep clean" after students and teachers returned from skiing trips in northern Italy over half term.

Ministers 'working with private companies' on new testing kit

In response to a question from former business secretary Greg Clark, Matt Han**** says the government is working with "around a dozen private companies" to bring in improved diagnostic equipment.

He says it would be better if the virus could be diagnosed at a patient's bedside instead of swabs being sent to a laboratory, as is currently the case.

Being out while waiting for sp to drop from 140 to 125 not good.
If an RNS lands when your out (or partially out), you'd kick yourself.

chimers, enjoy:

https://www.usbio.net/search/kits-and-assays/?promoCode=coronaPromo

I posted this earlier:
Novacyt requires cash with order, so if orders are increasing, so are profits.
Lets be having that RNS please..

https://www.boursorama.com/cours/1rPALNOV/

Assay results posted on Primerdesign twitter :

This would be a reference to the following:

https://www.rapidmicrobiology.com/news/primerdesign-the-first-european-team-to-deliver-to-the-world-a-2019-ncov-diagnostic-kit

See the last question:

Q: What will happen should the virus continue to mutate?

A: Viruses inherently have a high mutation rate. Should the targeted region of the virus mutate, the specificity of the assay may be reduced, which would be the same for any competitor kit or PCR assay. To combat this, as the sequence data is collected from newly 2019-nCoV infected patients from around the world and then published, our in-house bioinformatics team reviews this daily to check our detection assay has homology with all of these published sequences, and can still detect all positive 2019-nCoV samples.

Thus, the in-house bioinformatics team reviews newly published swab data, to ensure the detection assay can still detect all positive 2019-nCoV samples.
So as long as the bioinformatics team are kept busy with fresh data, medical authorities can be assured that Primerdesign knows how the virus is mutating (or not), and will instigate any measures required that assure the detection assay is still fit for purpose.

What we are seeing on twitter is the bioinformatics team confirming Assay results.
ie the 100% homology with all COVID-19 sequences on the NCBI database.

If Jeremy Corbin had won the last election, we'd have been nationalised by now..

RNS 06.12.2018 - Completion of q16 molecular diagnostics order.

This was 100 q16 Primerdesign instruments sent to China, suitable for testing with the new CE labelled test kit.

I have seen no feedback on their use in any articles I have read.
Perhaps some have been disassembled for cloning

Novacyt requires cash with order, so if orders are increasing, so is profits.
Lets be having that RNS please..

They said they had a 50% conversion rate, quotes to orders.
With the panic to get testing equipment in place, I would imagine the conversion rate is much higher now.
We have had no RNS to reflect what the new levels of interest are, and I suspect the Novocyt / Primerdesign management are in lengthy discussions with health officials of many countries, so no time to compile an RNS.
Rules are rules, and if orders are increasing, then share holders should be informed.

However another reason for no news may be because there is a takeover/jv/merger to be announced.

JM2c

Angry Ant

".. is that right,that Italy dont have any #NCYT test kits?"

With the number of immigrants entering Europe through Italy, you would think their need was greater than most.

Lets hope Greece have some, but in their financial condition perhaps that is a forlorn hope.

Over and out, need some decent rest for the off tomorrow.

gggg21 - I posted this on 21 Feb:

As pressure grows to find testing solutions, I believe the conversion rate will improve as the virus threat moves into top gear.

I've now listened to the CNN interview:

1 @ 03:28 "From a stock point of view we are able to fulfil all of the existing demand".

So a company who's job is to prepare and test for contagious deadly virus spread has been stock building.
- no surprise there, and he does not mention how many extra units he could supply immediately.

I doubt that this is the situation now though.

gggg21
Primerdesign do not accept any orders for anything without prepayment.
So the company won't create a cashflow problem trying to meet demand.
That just leaves the capacity of the production facilities at issue.

"The Centers for Disease Control and Prevention on Tuesday warned that it expects the novel coronavirus that has sparked outbreaks around the world to begin spreading at a community level in the United States, as a top official said that disruptions to daily life could be 'severe'.”

Mornington, - this was posted last night:

EU Rejects boarder checks.

https://www.dailymail.co.uk/news/article-8038243/Italian-bus-driver-sparks-coronavirus-panic-France.html

EU officials foresee a 'moderate to high' risk of more new coronavirus clusters sprouting up on continent

If only the left hand knew what the right hand was doing, and why..

http://www.primerdesign.co.uk/about/distributors

Just look how many distributors they have signed up globally.

This is the difference between Novocyt / Primerdesign and some less well established companies.

Use the 'Show Distributors for' field, and pick any small country. Most countries have a rep.

If you were a distributor, wouldn't you be pee'd off with the radio silence from the company?

Let's hope we hear from the company soon, with an obvious explanation, - merger/jv/takeover.

Tomorrow or Thursday announcement I'm thinking.

OK, so what %age of your trades are losers then - if you don't mind me asking.

The fact there is no news, effectively a blackout, from Novacyt / Primerdesign, indicates to me there is a merger/jv/takeover planned.

I know it must be difficult to report on such a fluid global situation, but why else would there be no updates.

Surely they would want to advise progress with the use of their equipment and test kits.

.. and CE label highly regarded in MENA countries.

posted last night but relevant here:

https://www.rapidmicrobiology.com/news/primerdesign-the-first-european-team-to-deliver-to-the-world-a-2019-ncov-diagnostic-kit

See the last question:

Q: What will happen should the virus continue to mutate?

A: Viruses inherently have a high mutation rate. Should the targeted region of the virus mutate, the specificity of the assay may be reduced, which would be the same for any competitor kit or PCR assay. To combat this, as the sequence data is collected from newly 2019-nCoV infected patients from around the world and then published, our in-house bioinformatics team reviews this daily to check our detection assay has homology with all of these published sequences, and can still detect all positive 2019-nCoV samples.

Thus, the in-house bioinformatics team reviews newly published swab data, to ensure the detection assay can still detect all positive 2019-nCoV samples.
So as long as the bioinformatics team are kept busy with fresh data, medical authorities can be assured that Primerdesign knows how the virus is mutating (or not), and will instigate any measures required that assure the detection assay is still fit for purpose.

How many competitors can make this claim?
This might be the reason why the CE mark has been awarded.

Because Trump has told them to base decisions on "America First", - it don't matter if the decision takes alittle longer..